Ophthalmology Risk Minimisation Materials
EYLEA® (aflibercept)
Here you can find links to the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for EYLEA® (aflibercept), via the Electronics Medicines Compendium (eMC), a resource providing information about all medicines available in the UK. Please note that this information is specific to Great Britain and is not intended to replace the advice of a qualified doctor. For more information on EYLEA or any related support, please contact the Bayer Medical Information team on 0118 206 3116, or email medical.information@bayer.co.uk.
EYLEA 8 mg Summary of Product Characteristics
EYLEA 8 mg Patient Information Leaflet
Prescriber guide video
Prescribing information for EYLEA® (aflibercept) can be found here.
EYLEA patient guides
All patient guides are recertified for use with original date of preparation.
PP-EYL-GB-2344 | August 2024